US Patent Innovations, LLC
US Patent Innovations, LLC is a holding company based out of Delaware and is the parent company for a family of innovative research & development, manufacturing, sales and distribution companies. USPI is controlled by a board of managers and has over 100 investment partners.
US Medical Innovations
US Medical Innovations, LLC (USMI), based out of Takoma Park, MD, is a privately-held FDA registered life science and biomedical device company. USMI is dedicated to expanding the boundaries of plasma medicine by pioneering new technologies for the development of state-of-the-art medical devices that advance patient outcomes and improve human lives. Leveraging the insights of USMI’s CEO and Co-Founder, as both a transplant surgeon and inventor, Dr. Canady continues to transition USMI to a Life Science company by investing its R&D in cancer therapies and robotics.
Canady Robotics, a subsidiary of US Patent Innovations, LLC is dedicated to the design and development of innovative robotic devices and applications for the medical field and beyond. Founded in 2014 and headquartered in Takoma Park, MD, the researchers and engineers of Canady Robotics represent an elite group of cutting-edge scientists who, in coordination with sister companies, Plasma Medicine Life Sciences and Canady Biotechnology, collaborate on the creation of new cross functional products and programs that continue to push the boundaries of the robotic and scientific frontier.
Founded in 2014 with a vision to create the best-engineered biomedical devices on the market, Canady Biotechnology is a manufacturing facility located in the heart of historic Takoma Park, MD. Our products are made with the highest quality materials and we take special care in thoroughly screening our suppliers to ensure that they share the same values and work ethic. Our engineers come from diverse backgrounds with a multitude of experience that allow them to design products tailored specifically to the complex needs of our client to ensure quality and integrity.
Plasma Medicine Life Sciences
At PMLS, innovation has been the focal point of our business since the company’s founding. To date, developing new plasma technologies and applications has been our core objective. Day after day, we invent new plasma technologies that are helping revolutionize the field of medicine. In doing so, PMLS makes an important contribution to the development of groundbreaking plasma processes and products.
JCRI-ABTS is a state-of-the-art research laboratory facility that strives for excellence in fields of research such as Biomedical, Proteomic, Molecular, Regenerative and Translational Biology. Our goal is to develop innovative technology and techniques that leverage plasma to treat and eventually cure cancer.